Author:
Pirmoradi Saeed,Hosseiniyan Khatibi Seyed Mahdi,Zununi Vahed Sepideh,Homaei Rad Hamed,Khamaneh Amir Mahdi,Akbarpour Zahra,Seyedrezazadeh Ensiyeh,Teshnehlab Mohammad,Chapman Kenneth R.,Ansarin Khalil
Abstract
AbstractSevere asthma is a chronic inflammatory airway disease with great therapeutic challenges. Understanding the genetic and molecular mechanisms of severe asthma may help identify therapeutic strategies for this complex condition. RNA expression data were analyzed using a combination of artificial intelligence methods to identify novel genes related to severe asthma. Through the ANOVA feature selection approach, 100 candidate genes were selected among 54,715 mRNAs in blood samples of patients with severe asthmatic and healthy groups. A deep learning model was used to validate the significance of the candidate genes. The accuracy, F1-score, AUC-ROC, and precision of the 100 genes were 83%, 0.86, 0.89, and 0.9, respectively. To discover hidden associations among selected genes, association rule mining was applied. The top 20 genes including the PTBP1, RAB11FIP3, APH1A, and MYD88 were recognized as the most frequent items among severe asthma association rules. The PTBP1 was found to be the most frequent gene associated with severe asthma among those 20 genes. PTBP1 was the gene most frequently associated with severe asthma among candidate genes. Identification of master genes involved in the initiation and development of asthma can offer novel targets for its diagnosis, prognosis, and targeted-signaling therapy.
Funder
National Institute for Medical Research Development
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. Masoli, M. et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5), 469–478 (2004).
2. Schofield, J. P. et al. A topological data analysis network model of asthma based on blood gene expression profiles. bioRxiv 13, 516328 (2019).
3. Bhalla, A., Mukherjee, M. & Nair, P. Airway eosinophilopoietic and autoimmune mechanisms of eosinophilia in severe asthma. Immunol. Allergy Clin. 38(4), 639–654 (2018).
4. Gruffydd-Jones, K. Unmet needs in asthma. Ther. Clin. Risk Manag. 15, 409 (2019).
5. Chung, K. F. et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 43(2), 343–373 (2014).